Below are the posts on the second and most recent trade.
The account purchased this stock at 2.35 and sold the September 2.50 call for .40 after commissions. As you will read in the posts, the stock shot up to past $5.00 but came down after a government product trial did not go the company's way. It is now sitting in the $2.00 range. The account will plan to look at what the November option price is before selling. The December option does hold some decent value. It would be better if we could squeeze out some value in the November time frame as the account continues to grow its capital base.
Trade 2 #1, Trade 2#2, Trade 2#3, Trade 2#4, Trade 2#5, Trade 2#6, Trade 2#7, Trade 2 #8, Trade 2#9